ITMI921413A0 - Preparazioni farmaceutiche stabili di nicorandil - Google Patents

Preparazioni farmaceutiche stabili di nicorandil

Info

Publication number
ITMI921413A0
ITMI921413A0 IT92MI1413A ITMI921413A ITMI921413A0 IT MI921413 A0 ITMI921413 A0 IT MI921413A0 IT 92MI1413 A IT92MI1413 A IT 92MI1413A IT MI921413 A ITMI921413 A IT MI921413A IT MI921413 A0 ITMI921413 A0 IT MI921413A0
Authority
IT
Italy
Prior art keywords
nicorandil
pharmaceutical preparations
stable pharmaceutical
stable
preparations
Prior art date
Application number
IT92MI1413A
Other languages
English (en)
Inventor
Paolo Alberto Veronesi
Anna Maria Veronesi
Original Assignee
Therapicon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon filed Critical Therapicon
Publication of ITMI921413A0 publication Critical patent/ITMI921413A0/it
Priority to ITMI921413A priority Critical patent/IT1256022B/it
Priority to MX9303165A priority patent/MX9303165A/es
Priority to JP5133290A priority patent/JP2893307B2/ja
Priority to KR1019930010224A priority patent/KR100196212B1/ko
Priority to EP93304427A priority patent/EP0574221B1/en
Priority to AT93304427T priority patent/ATE197671T1/de
Priority to DE69329691T priority patent/DE69329691T2/de
Priority to PT93304427T priority patent/PT574221E/pt
Priority to ES93304427T priority patent/ES2153835T3/es
Priority to US08/073,054 priority patent/US5580576A/en
Publication of ITMI921413A1 publication Critical patent/ITMI921413A1/it
Application granted granted Critical
Publication of IT1256022B publication Critical patent/IT1256022B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITMI921413A 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil IT1256022B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil
MX9303165A MX9303165A (es) 1992-06-08 1993-05-28 Preparaciones farmaceuticas estables de nicorandil
JP5133290A JP2893307B2 (ja) 1992-06-08 1993-06-03 ニコランジルの製薬的に安定な製剤
KR1019930010224A KR100196212B1 (ko) 1992-06-08 1993-06-07 니코란딜을 함유하는 안정한 약제조성물
EP93304427A EP0574221B1 (en) 1992-06-08 1993-06-08 Pharmaceutical stable formulations of nicorandil
AT93304427T ATE197671T1 (de) 1992-06-08 1993-06-08 Pharmazeutische stabile nicorandil-formulierungen
DE69329691T DE69329691T2 (de) 1992-06-08 1993-06-08 Pharmazeutische stabile Nicorandil-Formulierungen
PT93304427T PT574221E (pt) 1992-06-08 1993-06-08 Formulacoes farmaceuticas estaveis a base de nicorandil
ES93304427T ES2153835T3 (es) 1992-06-08 1993-06-08 Formulaciones farmaceuticas estables a base de nicorandil.
US08/073,054 US5580576A (en) 1992-06-08 1993-06-08 Pharmaceutically/storage-stable nicorandil formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil

Publications (3)

Publication Number Publication Date
ITMI921413A0 true ITMI921413A0 (it) 1992-06-08
ITMI921413A1 ITMI921413A1 (it) 1993-12-08
IT1256022B IT1256022B (it) 1995-11-20

Family

ID=11363474

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921413A IT1256022B (it) 1992-06-08 1992-06-08 Preparazioni farmaceutiche stabili di nicorandil

Country Status (10)

Country Link
US (1) US5580576A (it)
EP (1) EP0574221B1 (it)
JP (1) JP2893307B2 (it)
KR (1) KR100196212B1 (it)
AT (1) ATE197671T1 (it)
DE (1) DE69329691T2 (it)
ES (1) ES2153835T3 (it)
IT (1) IT1256022B (it)
MX (1) MX9303165A (it)
PT (1) PT574221E (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129673A (en) * 1998-06-08 2000-10-10 Advanced Monitors, Corp. Infrared thermometer
JP4472035B2 (ja) * 1998-06-17 2010-06-02 森下仁丹株式会社 長期保存安定性に優れたカプセル製剤
US20040151785A1 (en) * 1998-10-06 2004-08-05 Diamedica Inc. Method for treating insulin resistance through hepatic nitric oxide
DE50011819D1 (de) * 1999-03-12 2006-01-12 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
US8153161B2 (en) 2003-12-09 2012-04-10 Dainippon Sumitomo Pharma Co., Ltd. Medicament-containing particle and a solid preparation containing the particle
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
US20070281008A1 (en) * 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
PL2854841T3 (pl) 2012-06-04 2017-08-31 Diamedica Inc. Izoformy glikozylacji ludzkiej kalikreiny tkankowej 1
KR20190122706A (ko) 2017-03-09 2019-10-30 다이어메디카 인코포레이티드 조직 칼리크레인 1의 투약 형태
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPS6351326A (ja) * 1986-08-22 1988-03-04 Nisshin Flour Milling Co Ltd ニコランジル外用剤
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
MX9303165A (es) 1993-12-31
US5580576A (en) 1996-12-03
DE69329691D1 (de) 2000-12-28
JP2893307B2 (ja) 1999-05-17
ES2153835T3 (es) 2001-03-16
PT574221E (pt) 2001-04-30
KR100196212B1 (ko) 1999-06-15
JPH0640916A (ja) 1994-02-15
ITMI921413A1 (it) 1993-12-08
KR940000104A (ko) 1994-01-03
DE69329691T2 (de) 2001-05-10
ATE197671T1 (de) 2000-12-15
EP0574221A1 (en) 1993-12-15
EP0574221B1 (en) 2000-11-22
IT1256022B (it) 1995-11-20

Similar Documents

Publication Publication Date Title
DK0589843T3 (da) Cyclosporinholdige farmaceutiske præparater
DE59308338D1 (de) Kosmetische oder pharmazeutische Zubereitungen
DE69328492T2 (de) Fettsäure-derivate und diese enthaltende pharmazeutische präparationen
KR950700754A (ko) 신규의 약물(novel medicament)
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
BR1100329A (pt) Composto e formulação farmacêutica
ITMI921413A0 (it) Preparazioni farmaceutiche stabili di nicorandil
DE69326539D1 (de) Zytotoxische arzneimittel therapie
FI963883A (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
DE69632533D1 (de) Intrapulmonare verabreichung vom hematopoietischem medikament
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
ITMI20011389A0 (it) Formulazioni farmaceutiche acquose di cromoglicato sodico
DE69323568T2 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
NO951933D0 (no) Farmasöytiske formuleringer av ibuprofen
NO951350D0 (no) Farmasöytiske preparater inneholdende 3-substituerte 2-oksindol-1-karboksamider
BR9606066A (pt) Composto e formulação farmacêutica
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
FI940717A0 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
NO920039L (no) Farmasoeytiske preparater
FI932768A (fi) Farmaceutiska mjuka gelatinkapslar innehaollande lysinklonixinat och foerfarande foer framstaellning av dessa
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
DE69304453T2 (de) Pyridin-Derivate und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
0001 Granted